Benaroya Research Institute (BRI) is a world leader in human immunology, dedicated to predicting, preventing, reversing, and curing diseases of the immune system. With a strong focus in immunology, BRI studies a wide range of diseases including autoimmune diseases, allergies, asthma, cancer, and COVID-19. Collaborating with doctors and patients, BRI aims to accelerate the translation of innovative lab discoveries into life-changing patient care.

By creating detailed pictures of the immune system in both health and disease, BRI seeks to understand how disorders originate and how to restore the immune system to optimal health. As a nonprofit research institute within Virginia Mason Franciscan Health, BRI is committed to advancing human immunology by searching for new treatments with fewer side effects and personalized medicines that target the root cause of diseases. Through their Centers of Discovery, BRI conducts fundamental, translational, and clinical research, using advanced tools and innovative approaches to uncover groundbreaking insights.

BRI's ultimate goal is to achieve a healthy immune system for every individual